Bayer Radium Purchase

The Clatterbridge Cancer Centre NHS Foundation Trust, located at Clatterbridge Road, Bebington, has recently completed a procurement process titled "Bayer Radium Purchase" under the procurement category of goods, specifically involving various medicinal products and health services. This procurement process utilised a direct procurement method without competition, as it fell below the threshold. The award was made to Bayer PLC, a large-scale supplier based in Reading.

The contract involving the supply of Bayer Xofigo Radium 223 Dichloride was signed on 11th June 2025 and remained active through 13th June 2025. Important details of this procurement have been documented as of 30th July 2025. This tender presents significant opportunities for businesses operating in the medicinal products and healthcare services industry, particularly those capable of supplying specialised health products without the need for extensive competition.

The nature of this contract suggests that large-scale suppliers, similar to Bayer PLC, with the capacity to provide specialised, high-value medical goods may find excellent opportunities for growth. Such procurement processes are ideal for businesses aiming to partner with public authorities like NHS Foundation Trusts in delivering critical healthcare products, thereby expanding their market presence and enhancing business prospects in the healthcare sector.